Depressive DisordersMajor Depressive Disorder (MDD)Treatment-Resistant Depression (TRD)Neuroimaging & Brain MeasuresHealthy VolunteersKetamine

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder

This open-label between-subjects fMRI study (n=38) investigated the antidepressant effects of ketamine (35mg/70kg) with regard to changes in the neural correlates of emotional processing, 24 hours after infusion, in patients with major depression (n=18) compared to baseline measures from healthy volunteers (n=20). They found that ketamine rapidly increases brain responses to positive emotion, which correlated with increased connectivity of the right caudate during and improvement in depression severity.

Authors

  • Sanjay Mathew
  • James Murrough
  • Dennis Charney

Published

Translational Psychiatry
individual Study

Abstract

Introduction

The glutamate N-methyl-D-aspartate receptor antagonist ketamine has demonstrated antidepressant effects in individuals with treatment-resistant major depressive disorder (TRD) within 24 h of a single dose.

Methods

The current study utilized functional magnetic resonance imaging (fMRI) and two separate emotion perception tasks to examine the neural effects of ketamine in patients with TRD. One task used happy and neutral facial expressions; the other used sad and neutral facial expressions. Twenty patients with TRD free of concomitant antidepressant medication underwent fMRI at baseline and 24 h following administration of a single intravenous dose of ketamine (0.5 mg kg−1). Adequate data were available for 18 patients for each task. Twenty age- and sex-matched healthy volunteers were scanned at one time point for baseline comparison. Whole-brain, voxel-wise analyses were conducted controlling for a family-wise error rate (FWE) of P<0.05.

Results

Compared with healthy volunteers, TRD patients showed reduced neural responses to positive faces within the right caudate. Following ketamine, neural responses to positive faces were selectively increased within a similar region of right caudate. Connectivity analyses showed that greater connectivity of the right caudate during positive emotion perception was associated with improvement in depression severity following ketamine. No main effect of group was observed for the sad faces task.

Discussion

Our results indicate that ketamine specifically enhances neural responses to positive emotion within the right caudate in depressed individuals in a pattern that appears to reverse baseline deficits and that connectivity of this region may be important for the antidepressant effects of ketamine.

Available with Blossom Pro

Research Summary of 'Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder'

Introduction

Major depressive disorder (MDD) causes substantial disability and current treatments are often inadequate, particularly for people with treatment-resistant depression (TRD). Recent research has shown that the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine can produce rapid antidepressant effects within 24 h of a single administration, motivating investigation of glutamatergic mechanisms and the neurocircuitry that ketamine may regulate. Depression is associated with biased processing of social and emotional information, characterised by increased attention to negative stimuli and blunted responses to positive stimuli; neuroimaging studies have repeatedly implicated increased limbic responses to negative stimuli and reduced prefrontal–striatal responses to positive or reward-related stimuli in MDD. Murrough and colleagues set out to examine how a single ketamine infusion alters neural responses to positive and negative emotional facial expressions in unmedicated individuals with TRD. Using functional magnetic resonance imaging (fMRI) and two separate emotion perception tasks (happy versus neutral faces; sad versus neutral faces), the study aimed to characterise baseline group differences between TRD patients and healthy volunteers and to test whether ketamine rapidly normalises dysfunctional neural activation. The investigators further tested whether neural activation or task-related functional connectivity related to clinical improvement, measured as percent change in depression severity 24 h after ketamine.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (3)

Papers cited by this study that are also in Blossom

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A. et al. · Biological Psychiatry (2000)

Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

Murrough, J. W., Perez, A. M., Pillemer, S. et al. · Biological Psychiatry (2012)

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

Murrough, J. W., Iosifescu, D. V., Chang, L. C. et al. · American Journal of Psychiatry (2013)

Cited By (14)

Papers in Blossom that reference this study

Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study

Mallevays, M., Fuet, L., Danon, M. et al. · MedRvix (2026)

Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial

Rodrigues, L. S., Rossi, G. N., Guerra, L. T. L. et al. · Journal of Clinical Psychopharmacology (2024)

Biomarkers of ketamine's antidepressant effect: An umbrella review

Meshkat, S., Cao, B., Teopiz, K. M. et al. · Journal of Affective Disorders (2023)

Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence

Norbury, A., Rutter, S. B., Collins, A. B. et al. · Neuropsychopharmacology (2021)

38 cited
The anterior cingulate cortex as a key locus of ketamine’s antidepressant action

Alexander, L., Jelen, L. A., Mehta, M. A. et al. · Neuroscience and Biobehavioral Reviews (2021)

Targeting glutamate signalling in depression: progress and prospects

Murrough, J. W., Abdallah, C. G., Mathew, S. J. · Nature Reviews Drug Discovery (2021)

Show all 14 papers
Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature

Ionescu, D. F., Felicione, J. M., Gosai, A. et al. · Harvard Review of Psychiatry (2018)

Ketamine Treatment and Global Brain Connectivity in Major Depression

Abdallah, C. G., Averill, L. A., Collins, K. A. et al. · Neuropsychopharmacology (2016)

Ketamine for treatment-resistant depression: recent developments and clinical applications

Schwartz, J., Murrough, J. W., Iosifescu, D. V. · Evidence-Based Mental Health (2016)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.